Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices

    Implants / Devices - Page 18

    FIRST: Needle, syringe makers tell government to regulate their prices

    FIRST: Needle, syringe makers tell government to regulate their prices

    Medical Dialogues Bureau26 Sept 2018 3:41 PM IST
    New Delhi: All India Syringes and Needles Manufacturers Association (AISNMA) has written a letter to NELM on price capping of essential syringes and...
    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Medical Dialogues Bureau26 Sept 2018 9:48 AM IST
    The LithoVue Empower Device was developed in direct response to a need to improve procedural bottlenecks during kidney stone removal...
    Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

    Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

    Medical Dialogues Bureau24 Sept 2018 1:03 PM IST
    The move comes after complaints that patients had suffered due to faulty hip implants by a subsidiary of pharma giant Johnson and Johnson. New Delhi:...
    Soon Indian Standard for medical devices, says VK Paul

    Soon Indian Standard for medical devices, says VK Paul

    Medical Dialogues Bureau21 Sept 2018 1:37 PM IST
    New Delhi: A range of medical devices, old or new, will soon have an 'Indian standard' and nearly 1,000 products are presently being benchmarked, a...
    JnJ faulty hip implants case: CIC directs RTI disclosure of records

    JnJ faulty hip implants case: CIC directs RTI disclosure of records

    Ruby Khatun Khatun10 Sept 2018 12:26 PM IST
    New Delhi: A Johnson and Johnson subsidiary caught in a controversy over faulty hip replacement systems has opposed RTI disclosure of crucial...
    Johnson and Johnson says to work on India compensation for recalled hip implants

    Johnson and Johnson says to work on India compensation for recalled hip implants

    Ruby Khatun Khatun8 Sept 2018 10:30 AM IST
    MUMBAI: Johnson and Johnson said it would work with the Indian government to compensate patients who suffered from artificial hip implants the U.S....
    Medical device maker Stryker to buy K2M Group for about 1.4 billion

    Medical device maker Stryker to buy K2M Group for about 1.4 billion

    Ruby Khatun Khatun1 Sept 2018 9:47 AM IST
    Medical device maker Stryker Corp said it will buy smaller rival K2M Group Holdings Inc for about $1.4 billion, adding K2M's fast-growing spinal...
    Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

    Makers of the Alleged faulty Hip Implant objected to disclosure on import clearance, overruled by CIC

    Ruby Khatun Khatun30 Aug 2018 5:45 PM IST
    New Delhi: Importer of alleged faulty hip replacement systems had objected to disclosure of its compliance documents submitted to the Central Drugs...
    Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

    Why no Criminal action against Johnson and Johnson for faulty hip implants: Patients ask Nadda

    Ruby Khatun Khatun29 Aug 2018 3:35 PM IST
    New Delhi: A group of patients, who suffered due to alleged faulty hip replacement surgeries by a multinational firm, said that the Centre's response...
    Faulty Hip Implant Case Aftermath : Soon a Registry to track use of high-risk medical devices soon

    Faulty Hip Implant Case Aftermath : Soon a Registry to track use of high-risk medical devices soon

    Ruby Khatun Khatun27 Aug 2018 5:50 PM IST
    New Delhi: Soon a registry is going to take care of the use of medical devices which posses a high risk to the patients.TOI reports that the health...
    Johnson and Johnson Faulty Hip Implants: Ministry asks States to determine Compensation

    Johnson and Johnson Faulty Hip Implants: Ministry asks States to determine Compensation

    Ruby Khatun Khatun25 Aug 2018 5:44 PM IST
    The panel set up by the health ministry had recommended a base amount of Rs 20 lakh as compensation to each patient who had received the faulty hip...
    Medtronic reports about 6 pct rise in quarterly profit

    Medtronic reports about 6 pct rise in quarterly profit

    Medical Dialogues Bureau22 Aug 2018 7:06 PM IST
    Medical device maker Medtronic plc reported a near 6 per cent rise in quarterly profit on Tuesday, helped by higher sales in its cardiac and vascular...
    PrevNext

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok